| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.76B | 28.26B | 26.38B | 24.33B | 21.85B | 21.65B |
| Gross Profit | 13.52B | 13.02B | 3.97B | 3.17B | 2.05B | 2.47B |
| EBITDA | 5.64B | 5.36B | 4.21B | 3.60B | 2.89B | 3.58B |
| Net Income | 4.06B | 3.84B | 3.11B | 2.50B | 1.82B | 2.37B |
Balance Sheet | ||||||
| Total Assets | 86.32B | 86.00B | 80.92B | 70.10B | 73.02B | 76.58B |
| Cash, Cash Equivalents and Short-Term Investments | 4.39B | 4.49B | 4.25B | 126.00M | 4.09B | 46.75B |
| Total Debt | 4.37B | 4.37B | 4.37B | 4.36B | 4.36B | 4.94B |
| Total Liabilities | 67.43B | 67.02B | 64.47B | 54.77B | 59.39B | 58.73B |
| Stockholders Equity | 18.89B | 18.98B | 16.45B | 15.33B | 13.63B | 17.84B |
Cash Flow | ||||||
| Free Cash Flow | 5.82B | 5.75B | 5.76B | 4.00B | 3.83B | 3.96B |
| Operating Cash Flow | 5.98B | 5.92B | 5.91B | 4.22B | 4.01B | 4.09B |
| Investing Cash Flow | -3.69B | -3.76B | -3.77B | -2.43B | -1.28B | -2.41B |
| Financing Cash Flow | -2.29B | -2.23B | -2.08B | -1.95B | -2.71B | -1.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $37.46B | 10.99 | 22.01% | 1.55% | 6.90% | 41.67% | |
75 Outperform | $33.03B | ― | 21.07% | ― | 8.66% | ― | |
73 Outperform | $21.59B | 11.69 | 13.53% | 3.44% | -23.49% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $12.08B | 10.92 | 11.63% | 5.77% | 33.06% | 50.47% | |
62 Neutral | $39.59B | 15.62 | 7.50% | 2.02% | -19.92% | 7.41% | |
50 Neutral | $11.68B | 15.82 | -152.32% | 2.15% | -16.14% | -224.34% |